{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:28:02Z","timestamp":1787570882353,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05849-x","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:16:43Z","timestamp":1787570203000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety assessment of tenecteplase for the treatment of acute myocardial infarction and ischemic stroke, and identification of key genes"],"prefix":"10.1007","author":[{"given":"Hui","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayuan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"issue":"21","key":"5849_CR1","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1056\/NEJMra1606915","volume":"376","author":"JL Anderson","year":"2017","unstructured":"Anderson JL, Morrow DA (2017) Acute myocardial infarction. N Engl J Med 376(21):2053\u20132064","journal-title":"N Engl J Med"},{"issue":"15","key":"5849_CR2","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1056\/NEJMoa1301092","volume":"368","author":"PW Armstrong","year":"2013","unstructured":"Armstrong PW, Gershlick AH, Goldstein P et al (2013) Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med 368(15):1379\u20131387","journal-title":"N Engl J Med"},{"issue":"8","key":"5849_CR3","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.118.037137","volume":"139","author":"S Arora","year":"2019","unstructured":"Arora S, Stouffer GA, Kucharska-Newton AM et al (2019) Twenty Year trends and sex differences in young adults hospitalized with acute myocardial infarction. Circulation 139(8):1047\u20131056","journal-title":"Circulation"},{"issue":"13","key":"5849_CR4","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1001\/jama.2020.1511","volume":"323","author":"B Campbell","year":"2020","unstructured":"Campbell B, Mitchell PJ, Churilov L et al (2020) Effect of intravenous tenecteplase dose on cerebral reperfusion before thrombectomy in patients with large vessel occlusion ischemic stroke: the EXTEND-IA TNK part 2 randomized clinical trial. JAMA 323(13):1257\u20131265","journal-title":"JAMA"},{"issue":"Suppl 1","key":"5849_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000047782","volume":"13","author":"L Drouet","year":"2002","unstructured":"Drouet L (2002) Atherothrombosis as a systemic disease. Cerebrovasc Dis 13(Suppl 1):1\u20136","journal-title":"Cerebrovasc Dis"},{"issue":"9958","key":"5849_CR6","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","volume":"384","author":"J Emberson","year":"2014","unstructured":"Emberson J, Lees KR, Lyden P et al (2014) Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 384(9958):1929\u20131935","journal-title":"Lancet"},{"issue":"8 Suppl","key":"5849_CR7","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","volume":"47","author":"E Falk","year":"2006","unstructured":"Falk E (2006) Pathogenesis of atherosclerosis. J Am Coll Cardiol 47(8 Suppl):C7-12","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"5849_CR8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S1474-4422(19)30034-1","volume":"18","author":"GBD 2016 Stroke Collaborators","year":"2019","unstructured":"GBD 2016 Stroke Collaborators (2019) Global, regional, and national burden of stroke, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(5):439\u2013458","journal-title":"Lancet Neurol"},{"issue":"6","key":"5849_CR9","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.5114\/aoms.2016.58929","volume":"12","author":"A Guillermin","year":"2016","unstructured":"Guillermin A, Yan DJ, Perrier A, Marti C (2016) Safety and efficacy of tenecteplase versus alteplase in acute coronary syndrome: a systematic review and meta-analysis of randomized trials. Arch Med Sci 12(6):1181\u20131187","journal-title":"Arch Med Sci"},{"issue":"13","key":"5849_CR10","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","volume":"359","author":"W Hacke","year":"2008","unstructured":"Hacke W, Kaste M, Bluhmki E et al (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359(13):1317\u201329","journal-title":"N Engl J Med"},{"issue":"1","key":"5849_CR11","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1038\/s41598-025-85969-1","volume":"15","author":"X Jiang","year":"2025","unstructured":"Jiang X, Yuan R, Ye J, Wang X, Shi Z, Guo S (2025) Comparison of the safety and efficacy of dual antiplatelet therapy versus tenecteplase in patients with minor nondisabling acute ischemic stroke. Sci Rep 15(1):1685","journal-title":"Sci Rep"},{"issue":"9","key":"5849_CR12","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1073\/pnas.91.9.3670","volume":"91","author":"BA Keyt","year":"1994","unstructured":"Keyt BA, Paoni NF, Refino CJ et al (1994) A faster-acting and more potent form of tissue plasminogen activator. Proc Natl Acad Sci U S A 91(9):3670\u20133674","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9727","key":"5849_CR13","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/S0140-6736(10)60491-6","volume":"375","author":"KR Lees","year":"2010","unstructured":"Lees KR, Bluhmki E, von Kummer R et al (2010) Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 375(9727):1695\u2013703","journal-title":"Lancet"},{"issue":"1","key":"5849_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-024-04121-5","volume":"24","author":"F Liu","year":"2024","unstructured":"Liu F, Yang G, Xie J et al (2024) Adverse events of tissue plasminogen activators in acute myocardial infarction patients: a real-world and pharmacovigilance database analysis. BMC Cardiovasc Disord 24(1):441","journal-title":"BMC Cardiovasc Disord"},{"key":"5849_CR15","doi-asserted-by":"crossref","unstructured":"Ma P, Zhang Y, Chang L et al (2022) Tenecteplase vs. alteplase for the treatment of patients with acute ischemic stroke: a systematic review and\u00a0meta-analysis. J Neurol 269(10):5262\u20135271","DOI":"10.1007\/s00415-022-11242-4"},{"issue":"3","key":"5849_CR16","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/s13311-023-01391-3","volume":"20","author":"SE Miller","year":"2023","unstructured":"Miller SE, Warach SJ (2023) Evolving thrombolytics: from alteplase to tenecteplase. Neurotherapeutics 20(3):664\u2013678","journal-title":"Neurotherapeutics"},{"issue":"12","key":"5849_CR17","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1161\/01.ATV.0000189309.05924.88","volume":"25","author":"JJ Oliver","year":"2005","unstructured":"Oliver JJ, Webb DJ, Newby DE (2005) Stimulated tissue plasminogen activator release as a marker of endothelial function in humans. Arterioscler Thromb Vasc Biol 25(12):2470\u20132479","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5849_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1507196","volume":"15","author":"Q Qiao","year":"2024","unstructured":"Qiao Q, Sun J, Zheng Y et al (2024) Analysis of the risk of oncological adverse events associated with infliximab in combination with azathioprine compared to monotherapy: insights from the FAERS database. Front Pharmacol 15:1507196","journal-title":"Front Pharmacol"},{"issue":"4","key":"5849_CR19","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41569-022-00797-4","volume":"20","author":"V Regitz-Zagrosek","year":"2023","unstructured":"Regitz-Zagrosek V, Gebhard C (2023) Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes. Nat Rev Cardiol 20(4):236\u2013247","journal-title":"Nat Rev Cardiol"},{"issue":"25","key":"5849_CR20","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO et al (2020) Global burden of cardiovascular diseases and risk factors, 1990\u20132019: Update From the GBD 2019 Study. J Am Coll Cardiol 76(25):2982\u20133021","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"5849_CR21","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.036382","volume":"13","author":"A Saraf","year":"2024","unstructured":"Saraf A, Gilvaz PC, Ramakrishnan T et al (2024) Prospective observational cohort study of tenecteplase: results from the indian registry in ischemic stroke-tenecteplase. J Am Heart Assoc 13(23):e036382","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"5849_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2025.108300","volume":"34","author":"M Sheraz","year":"2025","unstructured":"Sheraz M, Asif N, Khan A et al (2025) Tenecteplase versus alteplase in patients with acute ischemic stroke: an updated meta-analysis of randomized controlled trials. J Stroke Cerebrovasc Dis 34(6):108300","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"5849_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/14740338.2023.2245745","volume":"23","author":"FE Shi","year":"2024","unstructured":"Shi FE, Yu Z, Sun C, Gao P, Zhang H, Zhu J (2024) Comparing adverse events of tenecteplase and alteplase: a real-world analysis of the FDA adverse event reporting system (FAERS). Expert Opin Drug Saf 23(2):221\u2013229","journal-title":"Expert Opin Drug Saf"},{"key":"5849_CR24","doi-asserted-by":"publisher","DOI":"10.48101\/ujms.v129.10459","author":"M Sk\u00e4rlund","year":"2024","unstructured":"Sk\u00e4rlund M, \u00c5sberg S, Eriksson M, Lundstr\u00f6m E (2024) Tenecteplase compared to alteplase in real-world outcome: a Swedish stroke register study. Ups J Med Sci. https:\/\/doi.org\/10.48101\/ujms.v129.10459","journal-title":"Ups J Med Sci"},{"issue":"2","key":"5849_CR25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/jcph.2164","volume":"63","author":"F Tang","year":"2023","unstructured":"Tang F, Langenhorst J, Dang S et al (2023) Population pharmacokinetics of tenecteplase in patients with acute myocardial infarction and application to patients with acute ischemic stroke. J Clin Pharmacol 63(2):197\u2013209","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"5849_CR26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s13760-018-0933-9","volume":"119","author":"A Thelengana","year":"2019","unstructured":"Thelengana A, Radhakrishnan DM, Prasad M, Kumar A, Prasad K (2019) Tenecteplase versus alteplase in acute ischemic stroke: systematic review and meta-analysis. Acta Neurol Belg 119(3):359\u2013367","journal-title":"Acta Neurol Belg"},{"issue":"5","key":"5849_CR27","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1177\/10600280221120211","volume":"57","author":"MN Walton","year":"2023","unstructured":"Walton MN, Hamilton LA, Salyer S, Wiseman BF, Forster AM, Rowe AS (2023) Major bleeding postadministration of tenecteplase versus alteplase in acute ischemic stroke. Ann Pharmacother 57(5):535\u2013543","journal-title":"Ann Pharmacother"},{"issue":"10377","key":"5849_CR28","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S0140-6736(22)02600-9","volume":"401","author":"Y Wang","year":"2023","unstructured":"Wang Y, Li S, Pan Y et al (2023) Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial. Lancet 401(10377):645\u2013654","journal-title":"Lancet"},{"key":"5849_CR29","doi-asserted-by":"publisher","first-page":"1440907","DOI":"10.3389\/fphar.2024.1440907","volume":"15","author":"XF Wang","year":"2024","unstructured":"Wang XF, Bao LR, Hu TL et al (2024) Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database. Front Pharmacol 15:1440907","journal-title":"Front Pharmacol"},{"issue":"3","key":"5849_CR30","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S et al (2021) clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2(3):100141","journal-title":"Innovation"},{"issue":"1","key":"5849_CR31","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2477301","volume":"57","author":"W Zhou","year":"2025","unstructured":"Zhou W, Li H, Zhang J et al (2025) Identification and mechanism analysis of biomarkers related to butyrate metabolism in COVID-19 patients. Ann Med 57(1):2477301","journal-title":"Ann Med"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05849-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05849-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05849-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:16:44Z","timestamp":1787570204000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05849-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":31,"alternative-id":["5849"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05849-x","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"assertion":[{"value":"10 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The data in this study were all obtained from previously published data. Since these data had already undergone ethical approval at the time of their original publication, this study does not require additional ethical approval or disclosure.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}